Trials / Conditions / Macular Telangiectasia Type 2 (MacTel)
Macular Telangiectasia Type 2 (MacTel)
3 registered clinical trials studyying Macular Telangiectasia Type 2 (MacTel) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Serine Supplementation to Protect Vision in MacTel NCT07342439 | The Lowy Medical Research Institute Limited | Phase 3 |
| Recruiting | Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants NCT06971939 | Neurotech Pharmaceuticals | Phase 4 |
| Completed | A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A NCT03316300 | Neurotech Pharmaceuticals | Phase 3 |